CANbridge Pharmaceuticals Enhances Governance with New Committee

CANbridge Pharmaceuticals Inc. ( (HK:1228) ) has provided an announcement.

CANbridge Pharmaceuticals Inc. has established a Nomination and Corporate Governance Committee, as resolved by its Board of Directors on June 21, 2021. This move is part of the company’s efforts to enhance its corporate governance structure, which could potentially strengthen its industry positioning and provide better oversight for stakeholders.

More about CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and commercialization of therapies for rare diseases and targeted cancers, with a market focus on innovative healthcare solutions.

Average Trading Volume: 5,299,196

Technical Sentiment Signal: Sell

Current Market Cap: HK$119M

Find detailed analytics on 1228 stock on TipRanks’ Stock Analysis page.